CABT-L2013

antibody from Creative Diagnostics
Targeting: PYGL GSD6
Provider product page for CABT-L2013
Western blot

Antibody data

Product number
CABT-L2013 - Provider product page
Provider
Creative Diagnostics
Product name
Rabbit Anti-Human PYGL Polyclonal Antibody
Antibody type
Polyclonal
Description
This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
Reactivity
Human, Rat
Host
Rabbit
Conjugate
Unconjugated
Isotype
IgG
Vial size
200 _g
Concentration
Lot specific
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
PYGL protein structure - CABT-L2013 shown in red.